NCT02827838 2025-03-17Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx CancerWake Forest University Health SciencesPhase EARLY_PHASE1 Terminated17 enrolled 12 charts
NCT03132467 2024-06-05Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast CancerM.D. Anderson Cancer CenterPhase EARLY_PHASE1 Completed16 enrolled 8 charts